Baby breathing treatment: gene test may end guesswork for albuterol in bronchiolitis
NCT ID NCT06946264
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a common asthma drug, albuterol, helps babies with bronchiolitis (a lung infection). Researchers will give 400 children either albuterol or a placebo and check their breathing. They will also collect DNA samples to see if certain genes predict who gets better. The goal is to create a tool that helps doctors decide when to use this treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Albuterol (a bronchodilator drug given as a mist)
What this could lead to
If successful, this could lead to a simple test to predict which children with bronchiolitis will benefit from albuterol, reducing unnecessary treatments and improving care.
What could go wrong
This is an early-stage study focused on finding genetic markers, not proving a cure. The results may not lead to immediate changes in treatment, and the genetic links may be weak or not generalizable.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHIOLITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nemours Children's Health
RECRUITINGOrlando, Florida, 32827, United States